Advertisement

Loading...

Irwin Naturals Inc.

IWIN.CNCNQ
Healthcare
Medical - Pharmaceuticals
$0.30
$0.00(0.00%)
Canadian Market is Open • 15:38

Irwin Naturals Inc. Fundamental Analysis

Irwin Naturals Inc. (IWIN.CN) shows weak financial fundamentals with a PE ratio of -0.08, profit margin of -4.46%, and ROE of -21.19%. The company generates $0.2B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position186.31%
PEG Ratio-0.00

Areas of Concern

ROE-21.19%
Operating Margin2.06%
We analyze IWIN.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -17.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-17.9/100

We analyze IWIN.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

IWIN.CN struggles to generate sufficient returns from assets.

ROA > 10%
-5.07%

Valuation Score

Excellent

IWIN.CN trades at attractive valuation levels.

PE < 25
-0.08
PEG Ratio < 2
-0.00

Growth Score

Weak

IWIN.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IWIN.CN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.92
Current Ratio > 1
1.24

Profitability Score

Weak

IWIN.CN struggles to sustain strong margins.

ROE > 15%
-2119.06%
Net Margin ≥ 15%
-4.46%
Positive Free Cash Flow
No

Key Financial Metrics

Is IWIN.CN Expensive or Cheap?

P/E Ratio

IWIN.CN trades at -0.08 times earnings. This suggests potential undervaluation.

-0.08

PEG Ratio

When adjusting for growth, IWIN.CN's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Irwin Naturals Inc. at 0.01 times its book value. This may indicate undervaluation.

0.01

EV/EBITDA

Enterprise value stands at -12.35 times EBITDA. This is generally considered low.

-12.35

How Well Does IWIN.CN Make Money?

Net Profit Margin

For every $100 in sales, Irwin Naturals Inc. keeps $-4.46 as profit after all expenses.

-4.46%

Operating Margin

Core operations generate 2.06 in profit for every $100 in revenue, before interest and taxes.

2.06%

ROE

Management delivers $-21.19 in profit for every $100 of shareholder equity.

-21.19%

ROA

Irwin Naturals Inc. generates $-5.07 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.07%

Following the Money - Real Cash Generation

Operating Cash Flow

Irwin Naturals Inc. generates limited operating cash flow of $-15.07M, signaling weaker underlying cash strength.

$-15.07M

Free Cash Flow

Irwin Naturals Inc. generates weak or negative free cash flow of $-15.41M, restricting financial flexibility.

$-15.41M

FCF Per Share

Each share generates $-4.55 in free cash annually.

$-4.55

FCF Yield

IWIN.CN converts -8.93% of its market value into free cash.

-8.93%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.08

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.01

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.008

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.92

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.24

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.21

vs 25 benchmark

ROA

Return on assets percentage

-0.05

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How IWIN.CN Stacks Against Its Sector Peers

MetricIWIN.CN ValueSector AveragePerformance
P/E Ratio-0.0827.91 Better (Cheaper)
ROE-21.19%687.00% Weak
Net Margin-4.46%-45285.00% (disorted) Weak
Debt/Equity0.920.33 Weak (High Leverage)
Current Ratio1.242795.76 Neutral
ROA-5.07%-13557.00% (disorted) Weak

IWIN.CN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Irwin Naturals Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ